243 related articles for article (PubMed ID: 38339070)
1. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
[TBL] [Abstract][Full Text] [Related]
2. New Horizons in cellular senescence for clinicians.
Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
[TBL] [Abstract][Full Text] [Related]
3. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
Englund DA; Zhang X; Aversa Z; LeBrasseur NK
Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic opportunities for senolysis in cardiovascular disease.
Sweeney M; Cook SA; Gil J
FEBS J; 2023 Mar; 290(5):1235-1255. PubMed ID: 35015342
[TBL] [Abstract][Full Text] [Related]
6. Application potential of senolytics in clinical treatment.
Li T; Li S; Ma K; Kong J
Biogerontology; 2024 Jun; 25(3):379-398. PubMed ID: 38109001
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies targeting cellular senescence for cancer and other diseases.
Wang X; Fukumoto T; Noma KI
J Biochem; 2024 Apr; 175(5):525-537. PubMed ID: 38366629
[TBL] [Abstract][Full Text] [Related]
8. Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells.
Morsli S; Doherty GJ; Muñoz-Espín D
Mech Ageing Dev; 2022 Mar; 202():111618. PubMed ID: 34990647
[TBL] [Abstract][Full Text] [Related]
9. Senolytic therapeutics: An emerging treatment modality for osteoarthritis.
Ansari MM; Ghosh M; Lee DS; Son YO
Ageing Res Rev; 2024 Apr; 96():102275. PubMed ID: 38494091
[TBL] [Abstract][Full Text] [Related]
10. Cellular senescence in cancer: molecular mechanisms and therapeutic targets.
Jin P; Duan X; Li L; Zhou P; Zou CG; Xie K
MedComm (2020); 2024 May; 5(5):e542. PubMed ID: 38660685
[TBL] [Abstract][Full Text] [Related]
11. Strategies for Targeting Senescent Cells in Human Disease.
Gasek NS; Kuchel GA; Kirkland JL; Xu M
Nat Aging; 2021 Oct; 1(10):870-879. PubMed ID: 34841261
[TBL] [Abstract][Full Text] [Related]
12. Cellular Senescence and Frailty in Transplantation.
Lorenz EC; Hickson LJ; Khairallah P; Najafi B; Kennedy CC
Curr Transplant Rep; 2023 Jun; 10(2):51-59. PubMed ID: 37576589
[TBL] [Abstract][Full Text] [Related]
13. The interplay between obesity, immunosenescence, and insulin resistance.
Shimi G; Sohouli MH; Ghorbani A; Shakery A; Zand H
Immun Ageing; 2024 Feb; 21(1):13. PubMed ID: 38317257
[TBL] [Abstract][Full Text] [Related]
14. Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice.
Chen P; Wang Y; Zhou B
Mech Ageing Dev; 2024 Apr; 218():111918. PubMed ID: 38401690
[TBL] [Abstract][Full Text] [Related]
15. Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging.
Mavrogonatou E; Kletsas D
Metabolites; 2024 Feb; 14(3):. PubMed ID: 38535306
[TBL] [Abstract][Full Text] [Related]
16. Effect of peripheral cellular senescence on brain aging and cognitive decline.
Budamagunta V; Kumar A; Rani A; Bean L; Manohar-Sindhu S; Yang Y; Zhou D; Foster TC
Aging Cell; 2023 May; 22(5):e13817. PubMed ID: 36959691
[TBL] [Abstract][Full Text] [Related]
17. Discovery of senolytics using machine learning.
Smer-Barreto V; Quintanilla A; Elliott RJR; Dawson JC; Sun J; Campa VM; Lorente-Macías Á; Unciti-Broceta A; Carragher NO; Acosta JC; Oyarzún DA
Nat Commun; 2023 Jun; 14(1):3445. PubMed ID: 37301862
[TBL] [Abstract][Full Text] [Related]
18. Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review).
Zhang Y; Chu J; Hou Q; Qian S; Wang Z; Yang Q; Song W; Dong L; Shi Z; Gao Y; Meng M; Zhang M; Zhang X; Chen Q
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757347
[TBL] [Abstract][Full Text] [Related]
19. COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells.
McHugh D; Sun B; Gutierrez-Muñoz C; Hernández-González F; Mellone M; Guiho R; Duran I; Pombo J; Pietrocola F; Birch J; Kallemeijn WW; Khadayate S; Dharmalingam G; Vernia S; Tate EW; Martínez-Barbera JP; Withers DJ; Thomas GJ; Serrano M; Gil J
Nat Cell Biol; 2023 Dec; 25(12):1804-1820. PubMed ID: 38012402
[TBL] [Abstract][Full Text] [Related]
20. Elimination of Senescent Osteocytes by Bone-Targeting Delivery of β-Galactose-Modified Maytansinoid Prevents Age-Related Bone Loss.
He Y; Zhang L; Chen X; Liu B; Shao X; Fang D; Lin J; Liu N; Lou Y; Qin J; Jiang Q; Guo B
Adv Healthc Mater; 2024 Mar; 13(8):e2302972. PubMed ID: 38063283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
